Wang, R., Stempel, J., Shallis, R., Bewersdorf, J. P., Mendez, L., Stahl, M., Zeidan, A., Ma, X., Podoltsev, N. (2025). Treatment initiation and first line tyrosine kinase inhibitor (TKI) selection for older patients with newly diagnosed chronic myeloid leukemia (CML) in the United States (US) before and after the introduction of generic imatinib (GE-IMA). Blood. https://doi.org/10.1182/blood-2025-6393